tiprankstipranks
Genocea Biosciences (GNCAQ)
OTHER OTC:GNCAQ
US Market

Genocea Biosciences (GNCAQ) Income Statement

Compare
738 Followers

Genocea Biosciences Income Statement

Last quarter (Q0 0), Genocea Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Genocea Biosciences's net income was $-15.98M. See Genocea Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 1.64M$ 1.36M$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 900.00K$ 500.00K$ ―$ -700.00K$ ―
EBITDA
$ -30.01M$ -40.74M$ -36.91M$ -25.70M$ -53.75M
Operating Income
$ -52.10M$ -46.99M$ -38.99M$ -39.52M$ -52.64M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -33.20M$ -43.71M$ -38.95M$ -27.81M$ -56.71M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Genocea Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis